Pfizer vaccine ‘highly effective and prevents serious illness’ – Israeli study

An Israeli military paramedic prepares a Pfizer Covid-19 vaccine (Tsafrir Abayov/AP)

A large-scale Israeli study has pointed to the efficacy of the Pfizer/BioNTech vaccine at preventing symptomatic infections with coronavirus.

Clalit, the largest of Israel’s four healthcare providers, released a study that compared infections in 600,000 Israelis who had received the vaccine with 600,000 who were not immunised.